Vontobel Holding Ltd. Sells 190 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Vontobel Holding Ltd. decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,876 shares of the biotechnology company’s stock after selling 190 shares during the quarter. Vontobel Holding Ltd.’s holdings in Axon Enterprise were worth $2,304,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in AXON. Groupama Asset Managment bought a new stake in Axon Enterprise in the 3rd quarter worth approximately $200,000. Massachusetts Financial Services Co. MA bought a new stake in Axon Enterprise in the 3rd quarter worth approximately $120,553,000. International Assets Investment Management LLC bought a new stake in Axon Enterprise in the 3rd quarter worth approximately $871,860,000. Westfield Capital Management Co. LP boosted its holdings in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 2.8 %

AXON opened at $683.41 on Monday. The firm has a market cap of $52.11 billion, a price-to-earnings ratio of 176.59, a PEG ratio of 6.79 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $260.27 and a 12 month high of $698.67. The stock has a fifty day moving average price of $623.22 and a 200-day moving average price of $509.17.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. JMP Securities lifted their target price on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 4th. Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Finally, Northland Securities boosted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $542.15.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the sale, the insider now owns 128,542 shares in the company, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 8,711 shares of company stock valued at $5,631,561. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.